Unique features of the mode of action of ET-743

Maurizio D'Incalci, Eugenio Erba, Giovanna Damia, Emanuela Galliera, Laura Carrassa, Sergio Marchini, Roberto Mantovani, Gianluca Tognon, Robert Fruscio, José Jimeno, Glynn T. Faircloth

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

This paper describes the current knowledge of the primary mode of action of a natural product, ecteinascidin 743 (ET-743), derived from the marine tunicate Ecteinascidia turbinata. ET-743 was initially selected for preclinical development because of its potent antitumor activity observed against several human solid tumor types. In vitro, the drug is cytotoxic in the nanomolar range, and in the case of some very sensitive cell lines, in the picomolar range. The large potency differences observed among several solid tumor types indicate that this compound possesses some tumor selectivity, but the molecular basis of these differential effects remains to be elucidated. The present studies were undertaken to evaluate the mechanism of action of ET-743 in this context. The available information on ET-743 binding to DNA and its effects on transcriptional regulation point to a unique behavior of this drug, as it independently affects specific gene transcription in a promoter-dependent way. In addition, ET-743 shows a peculiar pattern of selectivity in cells with different defects in their DNA-repair pathways. These results highlight a unique property of ET-743, possibly explaining why it possesses antitumor activity against tumors that are refractory to standard anticancer drugs, all of which certainly act by mechanisms that are different from that of ET-743.

Original languageEnglish
Pages (from-to)210-216
Number of pages7
JournalThe oncologist
Volume7
Issue number3
DOIs
Publication statusPublished - 2002

Fingerprint

trabectedin
Neoplasms
Pharmaceutical Preparations
Urochordata
Biological Products
DNA Repair

Keywords

  • Anticancer drug
  • ET-743
  • Marine compound
  • Natural product

ASJC Scopus subject areas

  • Cancer Research
  • Hematology

Cite this

Unique features of the mode of action of ET-743. / D'Incalci, Maurizio; Erba, Eugenio; Damia, Giovanna; Galliera, Emanuela; Carrassa, Laura; Marchini, Sergio; Mantovani, Roberto; Tognon, Gianluca; Fruscio, Robert; Jimeno, José; Faircloth, Glynn T.

In: The oncologist, Vol. 7, No. 3, 2002, p. 210-216.

Research output: Contribution to journalArticle

D'Incalci, M, Erba, E, Damia, G, Galliera, E, Carrassa, L, Marchini, S, Mantovani, R, Tognon, G, Fruscio, R, Jimeno, J & Faircloth, GT 2002, 'Unique features of the mode of action of ET-743', The oncologist, vol. 7, no. 3, pp. 210-216. https://doi.org/10.1634/theoncologist.7-3-210
D'Incalci, Maurizio ; Erba, Eugenio ; Damia, Giovanna ; Galliera, Emanuela ; Carrassa, Laura ; Marchini, Sergio ; Mantovani, Roberto ; Tognon, Gianluca ; Fruscio, Robert ; Jimeno, José ; Faircloth, Glynn T. / Unique features of the mode of action of ET-743. In: The oncologist. 2002 ; Vol. 7, No. 3. pp. 210-216.
@article{4b97058f993b44b087113782556ceca0,
title = "Unique features of the mode of action of ET-743",
abstract = "This paper describes the current knowledge of the primary mode of action of a natural product, ecteinascidin 743 (ET-743), derived from the marine tunicate Ecteinascidia turbinata. ET-743 was initially selected for preclinical development because of its potent antitumor activity observed against several human solid tumor types. In vitro, the drug is cytotoxic in the nanomolar range, and in the case of some very sensitive cell lines, in the picomolar range. The large potency differences observed among several solid tumor types indicate that this compound possesses some tumor selectivity, but the molecular basis of these differential effects remains to be elucidated. The present studies were undertaken to evaluate the mechanism of action of ET-743 in this context. The available information on ET-743 binding to DNA and its effects on transcriptional regulation point to a unique behavior of this drug, as it independently affects specific gene transcription in a promoter-dependent way. In addition, ET-743 shows a peculiar pattern of selectivity in cells with different defects in their DNA-repair pathways. These results highlight a unique property of ET-743, possibly explaining why it possesses antitumor activity against tumors that are refractory to standard anticancer drugs, all of which certainly act by mechanisms that are different from that of ET-743.",
keywords = "Anticancer drug, ET-743, Marine compound, Natural product",
author = "Maurizio D'Incalci and Eugenio Erba and Giovanna Damia and Emanuela Galliera and Laura Carrassa and Sergio Marchini and Roberto Mantovani and Gianluca Tognon and Robert Fruscio and Jos{\'e} Jimeno and Faircloth, {Glynn T.}",
year = "2002",
doi = "10.1634/theoncologist.7-3-210",
language = "English",
volume = "7",
pages = "210--216",
journal = "Oncologist",
issn = "1083-7159",
publisher = "Wiley Blackwell",
number = "3",

}

TY - JOUR

T1 - Unique features of the mode of action of ET-743

AU - D'Incalci, Maurizio

AU - Erba, Eugenio

AU - Damia, Giovanna

AU - Galliera, Emanuela

AU - Carrassa, Laura

AU - Marchini, Sergio

AU - Mantovani, Roberto

AU - Tognon, Gianluca

AU - Fruscio, Robert

AU - Jimeno, José

AU - Faircloth, Glynn T.

PY - 2002

Y1 - 2002

N2 - This paper describes the current knowledge of the primary mode of action of a natural product, ecteinascidin 743 (ET-743), derived from the marine tunicate Ecteinascidia turbinata. ET-743 was initially selected for preclinical development because of its potent antitumor activity observed against several human solid tumor types. In vitro, the drug is cytotoxic in the nanomolar range, and in the case of some very sensitive cell lines, in the picomolar range. The large potency differences observed among several solid tumor types indicate that this compound possesses some tumor selectivity, but the molecular basis of these differential effects remains to be elucidated. The present studies were undertaken to evaluate the mechanism of action of ET-743 in this context. The available information on ET-743 binding to DNA and its effects on transcriptional regulation point to a unique behavior of this drug, as it independently affects specific gene transcription in a promoter-dependent way. In addition, ET-743 shows a peculiar pattern of selectivity in cells with different defects in their DNA-repair pathways. These results highlight a unique property of ET-743, possibly explaining why it possesses antitumor activity against tumors that are refractory to standard anticancer drugs, all of which certainly act by mechanisms that are different from that of ET-743.

AB - This paper describes the current knowledge of the primary mode of action of a natural product, ecteinascidin 743 (ET-743), derived from the marine tunicate Ecteinascidia turbinata. ET-743 was initially selected for preclinical development because of its potent antitumor activity observed against several human solid tumor types. In vitro, the drug is cytotoxic in the nanomolar range, and in the case of some very sensitive cell lines, in the picomolar range. The large potency differences observed among several solid tumor types indicate that this compound possesses some tumor selectivity, but the molecular basis of these differential effects remains to be elucidated. The present studies were undertaken to evaluate the mechanism of action of ET-743 in this context. The available information on ET-743 binding to DNA and its effects on transcriptional regulation point to a unique behavior of this drug, as it independently affects specific gene transcription in a promoter-dependent way. In addition, ET-743 shows a peculiar pattern of selectivity in cells with different defects in their DNA-repair pathways. These results highlight a unique property of ET-743, possibly explaining why it possesses antitumor activity against tumors that are refractory to standard anticancer drugs, all of which certainly act by mechanisms that are different from that of ET-743.

KW - Anticancer drug

KW - ET-743

KW - Marine compound

KW - Natural product

UR - http://www.scopus.com/inward/record.url?scp=18444404938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18444404938&partnerID=8YFLogxK

U2 - 10.1634/theoncologist.7-3-210

DO - 10.1634/theoncologist.7-3-210

M3 - Article

VL - 7

SP - 210

EP - 216

JO - Oncologist

JF - Oncologist

SN - 1083-7159

IS - 3

ER -